XBI

Fund Description
The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the Index ). The S&P Biotechnology Select Industry represents the biotechnology segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The biotechnology segment of the S&P TMI comprises the Biotechnology sub-industry. The Index is modified equal weighted.
Fund Profile
Fund Name SPDR S&P Biotech ETF
Fund Exchange Ticker XBI
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A8707
Net Expense Ratio 0.35 %
Fund Inception Date 31 January 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Biotechnology Select Industry Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 26 January 2022
Asset Under Management 6068.97 Million (USD)
1 Month Total Return -22.21 %
Year To Date Return -19.98 %
1 Year Total Return -41.16 %
3 Year Annualized Total Return 3.92 %
NAV 89.7113
Share Outstanding 67,650,000
Top 10 Holdings (27 January 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
ARENA PHARMACEUTICALS INC ARNA EQUI 0.0181960300
BIOCRYST PHARMACEUTICALS INC BCRX EQUI 0.0122656000
BIOHAVEN PHARMACEUTICAL HOLD BHVN EQUI 0.0122304400
ALKERMES PLC ALKS EQUI 0.0113856200
EMERGENT BIOSOLUTIONS INC EBS EQUI 0.0111790800
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0110984400
INCYTE CORP INCY EQUI 0.0110773200
ABBVIE INC ABBV EQUI 0.0109681100
AMGEN INC AMGN EQUI 0.0107537000
EXELIXIS INC EXEL EQUI 0.0105885900